Calycosin attenuates dextran sulfate sodium (DSS)-induced experimental colitis
Objective(s):Inflammatory bowel disease (IBD) results from dysregulation of intestinal mucosal immunity. It is an incurable disease that affects millions of people worldwide. Developing new strategies for the treatment of colitis has been a major challenge. Here, we report the effect of calycosin, a...
Main Authors: | Liu Chao, Pengyuan Zheng, Liu Xia, Yu Yong, Gaofeng Lu, Fuai Tang, Zhiguo Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2017-08-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | http://ijbms.mums.ac.ir/article_9276_8caa298e9ba9d68fe2c98611219d4875.pdf |
Similar Items
-
Calycosin protects against chronic prostatitis in rats via inhibition of the p38MAPK/NF-κB pathway
by: Wang Heng, et al.
Published: (2023-08-01) -
Lactobacillus fermentum ZS40 Ameliorates Inflammation in Mice With Ulcerative Colitis Induced by Dextran Sulfate Sodium
by: Zixia Chen, et al.
Published: (2021-11-01) -
Calycosin inhibits gemcitabine-resistant lung cancer cells proliferation through modulation of the LDOC1/GNL3L/NFκB
by: Chi-Cheng Li, et al.
Published: (2023-01-01) -
Calycosin modulates NLRP3 and TXNIP-mediated pyroptotic signaling and attenuates diabetic nephropathy progression in diabetic rats; An insight
by: Haidy Yosri, et al.
Published: (2022-11-01) -
Calycosin attenuates the inflammatory damage of microglia induced by oxygen and glucose deprivation through the HMGB1/TLR4/NF-κB signaling pathway
by: Li Xiang, et al.
Published: (2023-08-01)